Hypothalamic—pituitary—adrenocortical axis responses to physostigmine: Effects of alzheimerʹs disease and gender

We asked whether hypothalamic—pituitary—adrenocortical (HPA) axis responses to a cholinergic stimulus are blunted in patients with Alzheimerʹs disease (AD) of mild to moderate severity. Such a finding would be consistent with a central cholinergic deficiency early in the course of AD. To address this question, we measured the plasma adrenocorticotropic hormone (ACTH), beta-endorphin-like immunoreactivity (βE-LI), and cortisol responses to the cholinesterase inhibitor physostigmine in 10 healthy normal older subjects (age = 71 ± 2 years) and 11 outpatients with probable AD (age = 72 ± 2 years; Mini Mental State Exam score = 19 ± 2). Cortisol concentrations were higher in AD subjects throughout the study, but AD and normal older subjects had similar robust ACTH, βE-LI, and cortisol responses to physostigmine. In all subjects combined, women had greater ACTH, βE-LI, and cortisol responses to physostigmine than did men. Plasma physostigmine concentrations did not differ between groups. These results suggest that female gender enhances the magnitude of HPA axis responses to cholinergic stimulation in older humans; however, the HPA axis response to physostigmine does not appear to reflect central cholinergic deficiency in the early stages of AD.